Journal Publications Details for:

Dendritic Cell Activation by Particulate Matter and Allergen
Grant Number R832139C004
RFA: Centers for Children's Environmental Health and Disease Prevention Research (2003)
Journal Article (7)
Reference Type Citation Progress Report Year Document Sources
Journal Article Georas SN. Inhaled glucocorticoids, lymphocytes, and dendritic cells in asthma and obstructive lung diseases. Proceedings of the American Thoracic Society 2004;1(3):215-221. R832139 (Final)
R832139C004 (Final)
Journal Article Georas SN, Guo J, De Fanis U, Casolaro V. T-helper type 2 regulation in allergic disease. European Respiratory Journal 2005;26(6):1119-1137. R832139 (2006)
R832139 (Final)
R832139C004 (Final)
Journal Article Georas SN, Berdyshev E, Hubbard W, Gorshkova IA, Usatyuk PV, Saatian B, Myers AC, Williams MA, Xiao HQ, Liu M, Natarajan V. Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge. Clinical and Experimental Allergy 2007;37(3):311-322. R832139 (2007)
R832139 (Final)
R832139C004 (Final)
Journal Article Williams MA, Porter M, Roman J, Breysse P, Williams D, Georas SN. Ambient Baltimore Particulate Matter Directs Non-Classical Immune Activation of Human Myeloid Dendritic Cells. Journal of Allergy and Clinical Immunology 2007;119(2):488-497. R832139 (2007)
R832139C004 (2007)
not available
Journal Article Williams MA, Cheadle C, Watkins T, Killedar S, Tailor A, Barnes K, Georas S. TLR2 and TLR4 are potential biomarkers of environmental particulate matter exposed human myeloid dendritic cells. Biomarker Insights 2007;2:225-239. R832139C004 (2007)
not available
Journal Article Williams MA, Bauer S, Lu W, Guo J, Walter S, Bushnell TP, Lillehoj EP, Georas SN. Deletion of the mucin-like molecule muc1 enhances dendritic cell activation in response to toll-like receptor ligands. Journal of Innate Immunity 2010;2(2):123-143. R832139 (Final)
R832139C004 (Final)
Journal Article Williams MC, Georas S. Gene expression patterns and susceptibility to allergic responses. Expert Review of Clinical Immunology 2006;2(1):59-73. R832139 (2006)
R832139 (2007)
R832139C001 (2007)
R832139C004 (2006)